Torfp g: to#6 "analytical support and PK sample analysis for preclinical pharmacology studies" period of performance: 09/16/2019 - 09/15/2024

Ended Awarded Last action

Contract number
75N91019F00130
Awardee
Awarding agency
Obligated
$59,335

Award facts

Contract value 100% obligated
$59,335.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Pittsburgh, PA 15213, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00003 -$8,348
Other Administrative Action P00002 · Analytical support of PK sample analysis for preclinical pharmacology studies $0
Exercise an Option P00001 · The purpose of this MOD is to exercise optional quantities and add funds under task order titled "analytical support and PK sample analysis for preclinical… $41,740
Original award $25,943

About this award

The National Cancer Institute issued a $59,335 delivery order to the University of Pittsburgh on September 16, 2019, for analytical support and pharmacokinetic sample analysis under the Pharmacokinetic and Pharmacology Evaluations for Cancer Patients IDIQ.

The order supports preclinical pharmacology studies evaluating agents in development for cancer patients. Work is performed in Pittsburgh, PA, under a firm fixed price structure. The period of performance runs from September 16, 2019, through September 15, 2024.

Quick answers

Who was awarded contract 75N91019F00130?

75N91019F00130 was awarded to University Of Pittsburgh - Of The Commonwealth System Of Higher Education by National Cancer Institute (National Institutes of Health) on September 16, 2019.

How much is contract 75N91019F00130 worth?

The government has obligated $59,335 on 75N91019F00130.

Is contract 75N91019F00130 an order under another contract?

Yes. 75N91019F00130 is a delivery order under HHSN261201600022I, an indefinite delivery contract, on Pharmacokinetic and Pharmacology Evaluations for Cancer Patients.

Was contract 75N91019F00130 competed?

The extent of competition for 75N91019F00130 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award